Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002222821 | SCV002499905 | uncertain significance | not provided | 2021-10-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV003164310 | SCV003909206 | uncertain significance | Inborn genetic diseases | 2023-03-06 | criteria provided, single submitter | clinical testing | The c.1291C>G (p.Q431E) alteration is located in exon 3 (coding exon 1) of the KCNA2 gene. This alteration results from a C to G substitution at nucleotide position 1291, causing the glutamine (Q) at amino acid position 431 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |